Department of Cancer Studies & Molecular Medicine, University of Leicester, LE1 5WW, United Kingdom.
J Affect Disord. 2012 Apr;138(1-2):137-48. doi: 10.1016/j.jad.2011.11.009. Epub 2012 Feb 5.
There have been few studies that have attempted to examine the phenomenology of comorbid depression, in particular the diagnostic value of individual somatic and non-somatic symptoms when attempting to diagnose depression following cancer.
We approached 279 patients up to three times within 9 months of first presentation with a diagnosis of cancer, and collected data following a total of 558 contacts. 176 contacts (31%) were in a palliative stage. Symptoms were elicited by self-report PHQ9 and HADS-D scales. The prevalence of major depression was 12.7% but 29.6% had major or minor depression (any depressive disorder) according to modified DSMIV criteria.
All symptoms of depression were significant more common in depressed versus non-depressed cancer patients regardless of stage. Against broadly defined any depressive disorder (ADD) the most accurate diagnostic symptoms were all somatic (namely trouble falling or staying asleep or sleeping too much; feeling tired or having little energy; poor appetite or overeating; trouble concentrating on things such as reading). Indeed the optimal symptom insomnia had good case-finding properties and screening properties used alone. A two step combination of three questions give a sensitivity of 100% and specificity of 91.6% against ADD. Against major depressive disorder (MDD) both somatic and non-somatic symptoms were valuable (including but not limited to the PHQ2 stem questions). Only low energy was poorly discriminating which may suggest that the standard ICD10 criteria may not be optimal. When considering depression as defined by the HADS-D (≥ 11), then the three most influential symptoms were psychological closely followed by somatic symptoms. When looking for MDD and HADS-D depression, no single symptom was a good proxy for depression highlighting a possible shortcoming if clinicians attempt to rely on one single question. In a subset of palliative patients feeling bad about yourself and moving or speaking slowly were less influential and outperformed by poor appetite/overeating and feeling tired or having little energy.
This research suggests that most somatic symptoms remain influential when diagnosing depression in the context of cancer and hence should not be omitted indiscriminately, even in palliative stages. The optimal symptoms for diagnosing depression will depend on whether a narrow concept of depression or a broad concept of depression is considered clinically important.
很少有研究试图探讨共病抑郁的现象学,特别是在癌症后试图诊断抑郁症时,个体躯体和非躯体症状的诊断价值。
我们在首次确诊癌症后 9 个月内,分三次接触了 279 名患者,并在总共 558 次接触后收集了数据。176 次接触(31%)处于姑息阶段。症状通过自我报告 PHQ9 和 HADS-D 量表来引出。重度抑郁症的患病率为 12.7%,但根据修改后的 DSMIV 标准,有 29.6%的患者患有重度或轻度抑郁症(任何抑郁障碍)。
无论处于哪个阶段,患有抑郁症的癌症患者的所有抑郁症状都明显更为常见。与广泛定义的任何抑郁障碍(ADD)相比,最准确的诊断症状都是躯体症状(即入睡或保持睡眠困难或睡眠过多;感到疲倦或精力不足;食欲不振或暴饮暴食;难以集中注意力阅读等)。事实上,单独使用最佳症状失眠就具有良好的病例发现特性和筛查特性。三步结合三个问题,对 ADD 的敏感性为 100%,特异性为 91.6%。对于重度抑郁症(MDD),躯体和非躯体症状都有价值(包括但不限于 PHQ2 起始问题)。只有低能量的区分度较差,这可能表明标准的 ICD10 标准可能不是最优的。当考虑到 HADS-D(≥11)定义的抑郁时,三个最有影响力的症状是心理症状,紧随其后的是躯体症状。当寻找 MDD 和 HADS-D 抑郁时,没有一个单一的症状可以很好地代表抑郁,这突出了如果临床医生试图依赖一个单一的问题,可能存在一个缺陷。在姑息治疗患者的亚组中,对自己感觉不好、行动或说话缓慢的影响较小,而食欲不振/暴饮暴食和疲倦或精力不足的影响更大。
这项研究表明,即使在姑息阶段,大多数躯体症状在癌症背景下诊断抑郁症时仍然具有影响力,因此不应不加区分地省略。用于诊断抑郁症的最佳症状将取决于是否将狭义的抑郁症概念或广义的抑郁症概念视为临床上重要的概念。